KIDS
ORTHOPEDIATRICS CORP
-1.02 (-4.42%)22.13USD90.3K成交股數578M市值–本益比(近四季)2.3股價營收比+15.4%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 70.5M+15% | 59.4M+13% | 61.6M+13% | 61.3M+16% | 61.1M+37% | 52.4M+39% | 54.6M+37% | 52.8M+33% | 44.7M | 37.6M | 40.0M | 39.6M |
| 營業成本 | 18.1M | 16.0M | 16.5M | 16.0M | 17.1M | 14.1M | 14.5M | 12.0M | 12.5M | 10.9M | 9.0M | 9.5M |
| 毛利 | 52.4M+19% | 43.4M+13% | 45.1M+13% | 45.3M+11% | 44.0M+37% | 38.3M+43% | 40.1M+29% | 40.8M+36% | 32.2M | 26.7M | 31.0M | 30.0M |
| 毛利率 | 74.3% | 73.1% | 73.2% | 73.9% | 72.1% | 73.0% | 73.4% | 77.3% | 72.0% | 71.0% | 77.4% | 75.9% |
| 研發費用 | 2.3M | 2.2M | 2.3M | 2.3M | 2.2M | 2.4M | 2.6M | 2.5M | 3.0M | 2.9M | 2.6M | 3.0M |
| 銷售管理費用 | 32.8M | 31.0M | 30.0M | 29.2M | 30.4M | 30.3M | 26.3M | 27.3M | 24.7M | 19.1M | 18.0M | 19.1M |
| 營業利益 | −4.1M-62% | −8.3M-24% | −8.2M+47% | −9.4M+66% | −10.7M+10% | −11.0M+36% | −5.6M+23% | −5.7M+1% | −9.7M | −8.1M | −4.5M | −5.6M |
| 營業利益率 | -5.8% | -14.0% | -13.3% | -15.4% | -17.4% | -21.0% | -10.2% | -10.7% | -21.8% | -21.4% | -11.3% | -14.1% |
| 稅後淨利 | −7.2M+1% | −10.7M+0% | −10.1M+28% | −11.8M+95% | −7.1M-9% | −10.7M+59% | −7.9M+72% | −6.0M+109% | −7.8M | −6.7M | −4.6M | −2.9M |
| 淨利率 | -10.2% | -18.0% | -16.4% | -19.2% | -11.6% | -20.3% | -14.5% | -11.4% | -17.5% | -17.8% | -11.5% | -7.3% |
| 稀釋 EPS | -0.300% | -0.45-2% | -0.43+26% | -0.50+92% | -0.30-12% | -0.46+59% | -0.34+70% | -0.26+100% | -0.34 | -0.29 | -0.20 | -0.13 |
| 稀釋股數 | 24.0M | 23.7M | 23.5M | 23.6M | 23.5M | 23.2M | 23.2M | 23.1M | 22.8M | 22.7M | 22.8M | 22.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.0M | 12.2M | 19.6M | 16.8M | 44.6M | 33.4M | 51.0M | 28.9M | 21.6M | 31.1M | 10.6M | 9.7M |
| 應收帳款 | 61.0M | 54.4M | 53.8M | 51.3M | 53.8M | 44.0M | 42.8M | 42.0M | 36.3M | 34.6M | 37.6M | 33.8M |
| 存貨 | 138M | 134M | 134M | 129M | 125M | 120M | 121M | 116M | 113M | 106M | 101M | 91.0M |
| 總資產 | 511M | 502M | 509M | 493M | 504M | 470M | 489M | 431M | 437M | 439M | 432M | 435M |
| 有息負債 | 99.5M | 100M | 99.8M | 99.2M | 97.0M | 73.0M | 72.5M | 9.8M | 10.2M | 9.9M | – | – |
| 總負債 | 168M | 163M | 162M | 144M | 148M | 123M | 118M | 59.5M | 66.6M | 61.7M | 58.1M | 54.6M |
| 股東權益 | 344M | 339M | 347M | 349M | 356M | 347M | 371M | 371M | 371M | 377M | 374M | 380M |
| 負債比 | 32.8% | 32.6% | 31.9% | 29.2% | 29.4% | 26.2% | 24.2% | 13.8% | 15.2% | 14.1% | 13.4% | 12.5% |
| 淨現金(現金 − 有息負債) | −82.5M | −88.2M | −80.3M | −82.3M | −52.5M | −39.6M | −21.5M | 19.1M | 11.5M | 21.1M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.3M-21% | – | – | – | −4.2M | – | – | −6.7M | – | – | – |
| 資本支出 | – | 1.8M | – | – | – | 4.2M | – | – | 6.5M | – | – | – |
| 自由現金流 | – | −5.0M-40% | – | – | – | −8.4M | – | – | −13.2M | – | – | – |
| 折舊攤銷 | – | 5.7M | – | – | – | 5.0M | – | – | 5.0M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -8.5% | – | – | – | -16.0% | – | – | -29.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 236M
| 美國 | 186M | 78.9% | +15.7% |
|---|---|---|---|
| 美國以外 | 49.9M | 21.1% | +14.6% |
產品/服務2025 年度 · 236M
| Traumaand Deformity | 166M | 70.4% | +14.6% |
|---|---|---|---|
| Spine | 66.0M | 27.9% | +19.8% |
| Sports Medicine And Other | 4.0M | 1.7% | -10.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 236M | +15.4% | −39.6M | -16.8% | -1.69 | −16.0M |
| FY2024 | 205M | +37.6% | −37.8M | -18.5% | -1.64 | −41.3M |
| FY2023 | 149M | +21.6% | −21.0M | -14.1% | -0.92 | −43.9M |
| FY2022 | 122M | +24.7% | 1.3M | 1.0% | 0.06 | −31.8M |
| FY2021 | 98.0M | +37.9% | −16.3M | -16.6% | -0.84 | −21.2M |
| FY2020 | 71.1M | -2.0% | −32.9M | -46.3% | -1.82 | −29.0M |
| FY2019 | 72.6M | +26.0% | −13.7M | -18.9% | -0.94 | −29.6M |
| FY2018 | 57.6M | – | −12.0M | -20.9% | -0.96 | −20.8M |